Genomma Lab B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genomma Lab Internacional SAB De CV (LABB)
The Genomma Lab Int share price today is 16.480, view BMV LABB stock exchange data. Track the latest Genomma Lab Int share price with real-time updates on LABB stock performance including market cap, day range, 52-week range and dividend yield. Access LABB charts, earnings dates and analyst estimates to support your investment decisions.
16.480
+0.190(+1.17%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.200
16.680
52 wk Range
15.890
23.920
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.20016.680
52 wk Range
15.89023.920
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.91%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LABB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
26.200
Upside
+58.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 26.200
(+58.98% Upside)
Earnings
Latest Release
23-04-2026
EPS / Forecast
0.49 / 0.45
Revenue / Forecast
4.19B / 4.18B
Compare LABB to Peers and Sector
Metrics to compare | LABB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLABBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.0x | −3.1x | −0.5x | |
PEG Ratio | −0.38 | 0.14 | 0.00 | |
Price/Book | 1.4x | 1.7x | 2.6x | |
Price / LTM Sales | 0.9x | 2.1x | 3.2x | |
Upside (Analyst Target) | 69.9% | 86.7% | 47.8% | |
Fair Value Upside | Unlock | 23.4% | 6.7% | Unlock |
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Genomma Lab Int (LABB) Share Price Today?
The Genomma Lab Int share price today is 16.480.
What is the current Genomma Lab Int (LABB) share price and day range?
As of 02-05-2026, the Genomma Lab Int share price is 16.480, with a previous close of 16.290. The share price has ranged from 16.200 to 16.680 today, while the 52-week range spans from 15.890 to 23.920.
What Is the Genomma Lab Int Market Cap?
As of today, Genomma Lab Int market cap is 16.100B.
Does Genomma Lab Int Pay Dividends? What's The Current Dividend Yield?
The Genomma Lab Int dividend yield is 4.91%.
What Is the Genomma Lab Int (LABB) Share Price Target?
The average 12-month share price target for Genomma Lab Int is 26.200, with a high estimate of 30 and a low estimate of 20. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +58.98% Upside potential.
What Is Genomma Lab Int's Earnings Per Share (TTM)?
The Genomma Lab Int EPS (TTM) is 1.642.
When Is the Next Genomma Lab Int Earnings Date?
Genomma Lab Int will release its next earnings report on 29-07-2026.
From a Technical Analysis Perspective, Is LABB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Genomma Lab Int Trade On?
Genomma Lab Int is listed and trades on the Mexico Stock Exchange.
What Is the Stock Symbol for Genomma Lab Int?
The stock symbol for Genomma Lab Int is "LABB."
How Many Times Has Genomma Lab Int Stock Split?
Genomma Lab Int has split 1 times.
How Many Employees Does Genomma Lab Int Have?
Genomma Lab Int has 1465 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.